IMS HEALTH is the World's leading provider of information solutions to the pharmaceutical industry operating in over 90 countries and with over 40 years experience. IMS HEALTH Global Services offers information, expertise and consultancy to assist market research in all critical phases of pharmaceutical product planning, launch, sales, marketing and financial analysis. Our comprehensive range of products and services provide the key to the changing pharmaceutical industry - what's happening, where, and how it will affect your business. They deliver "timely" data, with added insight and analysis, in easily accessible formats.
| Contact Details: |
| 7 Harewood Avenue |
| London |
| Greater London |
| NW1 6JB |
| United KIngdom |
| Tel: | +44 (0)207 393 5000 |
| Fax: | +44 (0)207 393 5999 |
| Email: | pjenner@uk.imshealth.com |
| WWW: | www.imshealth.com/
|
| |
Recent Publications by ims health: |  |
Photodynamic therapy using methyl aminolevulinate in the management of primary superficial basal cell carcinoma: clinical and health economic outcomes.
BACKGROUND: Basal cell carcinoma (BCC) is the most common form of skin... | 10th November, 2009
| Health Economics and Outcomes Research, IMS Health, Brussels, Belgium.
| J Drugs Dermatol. 2009 Nov;8(11):992-6.
|
Economic outcomes associated with microvascular complications of type 2 diabetes mellitus: results from a US claims data analysis.
BACKGROUND: Patients with diabetes mellitus have been shown to be at high... | 22nd October, 2009
| Health Economics and Outcomes Research, IMS Health Incorporated,
| Pharmacoeconomics. 2009;27(6):479-90. doi:
DOI Direct Link |
The consequences of delaying insulin initiation in UK type 2 diabetes patients failing oral hyperglycaemic agents: a modelling study.
ABSTRACT: BACKGROUND: Recent data have shown that type 2 diabetes patients... | 7th October, 2009
| IMS
| BMC Endocr Disord. 2009 Oct 5;9:19.
DOI Direct Link |
Are High-Risk Hypertensive Patients being Prescribed Concomitant Statin Therapy?: A Retrospective Cohort Study.
Treatment guidelines for dyslipidemic patients have focused on lipid... | 2nd October, 2009
| Health Economics and Outcomes Research, IMS Health, Falls Church,
| Am J Cardiovasc Drugs. 2009;9(5):299-308. doi:
DOI Direct Link |
An estimation of the long-term clinical and economic benefits of insulin lispro in Type 1 diabetes in the UK.
AIMS: To determine the long-term health economic benefits associated with... | 28th August, 2009
| IMS Health,
| Diabet Med. 2009 Aug;26(8):803-14.
DOI Direct Link |
→View more ims health research publications. |
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 346 times since April 2007, the link to the organisation's website has been followed 64 times
Search for more companies in London
Search for more companies in Greater London
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
ims health
